LeonaBio, Inc.

NASDAQ: LONA · Healthcare · Biotechnology

PublicHQ Bothell, WA · KingCIK 0001620463Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 29DQ —GM —SS 40

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, market scale · ↓ return on equity, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$105.6M

Employees

as of 2026-08-20

Market cap

$30.9M

as of 2026-08-20

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$105.6M-$105.6M2025

Operating income-$102.3M-$102.3M2025

Total assets$92.2M$92.2M2025

Liabilities$64.4M$64.4M2025

Equity$27.8M$27.8M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is LeonaBio, Inc.’s financial profile?

LeonaBio, Inc. earned -$105.6M in FY2025 net income.

Peers · Healthcare

MIRA Pharmaceuticals, Inc.——Lantern Pharma Inc.——Estrella Immunopharma, Inc.——Sernova Corp.——Sangamo Therapeutics, Inc.——HeartBeam, Inc.——

Neighbors

King →

Microsoft Corporation$281.7B89A Amazon.com, Inc.$716.9B87A Costco Wholesale Corporation$275.2B84B+T-Mobile US, Inc.$88.3B84B+Starbucks Corporation$37.2B74B PACCAR Inc$28.4B74B

Key facts

CEOMark J. Litton

SectorHealthcare

IndustryBiotechnology

HeadquartersBothell, WA

ExchangeNASDAQ: LONA

Employees19

IPO date2020-09-18

Latest filings

8-K2026-08-26 10-Q2026-08-14 8-K2026-08-14 8-K2026-06-23 DEF 14A2026-05-11 8-K2026-05-07 10-Q2026-05-07 10-K2026-03-31

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.